Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. AnaptysBio Inc shares valued at $238,960 were sold by LOUMEAU ERIC J on Sep 30 ’25. At $29.00 per share, LOUMEAU ERIC J sold 8,240 shares. The insider’s holdings dropped to 9,088 shares worth approximately $0.31 million following the completion of this transaction.
Also, ERIC J LOUMEAU purchased 8,240 shares, netting a total of over 238,960 in proceeds.
Before that, RENTON HOLLINGS had sold 10,231 shares from its account. In a trade valued at $200,714, the Director traded AnaptysBio Inc shares for $19.62 each. Upon closing the transaction, the insider’s holdings decreased to 10,231 shares, worth approximately $0.17 million.
As published in their initiating research note from Barclays on October 13, 2025, AnaptysBio Inc [ANAB] has been an Overweight and the price target has been revised to $78. Analysts at H.C. Wainwright upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in early June. As of February 04, 2025, Wolfe Research has initiated its “an Outperform” rating for ANAB. Earlier on December 11, 2024, H.C. Wainwright downgraded its rating. Their new recommendation was “a Neutral” for ANAB stock which previously was a “a Buy”.
Analyzing ANAB Stock Performance
On last trading session, AnaptysBio Inc [NASDAQ: ANAB] rose 7.66% to $34.29. The stock’s lowest price that day was $31.55, but it reached a high of $34.415 in the same session. During the last five days, there has been a surge of approximately 7.73%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 3.22%.
Is AnaptysBio Inc subject to short interest?
Stocks of AnaptysBio Inc saw a sharp steep in short interest on 2025-09-30 dropping by -2.53 million shares to 7.16 million. Data from Yahoo Finance shows that the short interest on 2025-08-29 was 9.7 million shares. A decline of -35.39% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 9.88 of the overall float, the days-to-cover ratio (short ratio) decline to 9.88.
Which companies own the most shares of AnaptysBio Inc (ANAB)?
In terms of AnaptysBio Inc share price expectations, FactSet research, analysts set an average price target of 64.5 in the next 12 months, up nearly 102.51% from the previous closing price of $31.85. Analysts anticipate AnaptysBio Inc stock to reach 78 by 2025, with the lowest price target being 54. In spite of this, 6 analysts ranked AnaptysBio Inc stock as Buy at the end of 2025.
